BMC Infectious Diseases (Dec 2023)

Characteristics of blood immune cell profile and their correlation with disease progression in patients infected with HIV-1

  • Xiao-Yan Guo,
  • Meng-Meng Qu,
  • Xi Wang,
  • Ze-Rui Wang,
  • Jin-Wen Song,
  • Bao-Peng Yang,
  • Yun-Tian Guo,
  • Yang Zhang,
  • Chao Zhang,
  • Xing Fan,
  • Wen Xu,
  • Ruonan Xu,
  • Ji-Yuan Zhang,
  • Si-Yuan Chen,
  • Yan-Mei Jiao,
  • Li-Jun Sun,
  • Fu-Sheng Wang

DOI
https://doi.org/10.1186/s12879-023-08847-z
Journal volume & issue
Vol. 23, no. 1
pp. 1 – 16

Abstract

Read online

Abstract Background Antiretroviral therapy (ART) can reduce viral load in individuals infected with human immunodeficiency virus (HIV); however, some HIV-infected individuals still cannot achieve optimal immune recovery even after ART. Hence, we described the profile of peripheral immune cells and explored the association with disease progression in patients infected with HIV-1. Methods Mass cytometry analysis was used to characterize the circulating immune cells of 20 treatment-naïve (TNs), 20 immunological non-responders (INRs), 20 immunological responders (IRs), and 10 healthy controls (HCs). Correlation analysis was conducted between cell subpopulation percentages and indicators including HIV-1 cell-associated (CA)-RNA, DNA, CD4+ T cell count, and CD4/CD8 ratio. Results Global activation, immunosenescence, and exhaustion phenotypes were observed in myeloid cells and T cells from individuals with HIV-1 infection. We also found that specific subsets or clusters of myeloid, CD4+ T, and CD8+ T cells were significantly lost or increased in TN individuals, which could be partially restored after receiving ART. The percentages of several subpopulations correlated with HIV-1 CA-RNA, DNA, CD4+ T cell count, and CD4/CD8 ratio, suggesting that changes in immune cell composition were associated with therapeutic efficacy. Conclusion These data provide a complete profile of immune cell subpopulations or clusters that are associated with disease progression during chronic HIV-1 infection, which will improve understanding regarding the mechanism of incomplete immune recovery in INRs.

Keywords